Evexia Lifecare Shares Extend Gains Amid High Trading Activity
The share price of Evexia Lifecare continued its upward movement for the second straight session on Monday, registering a notable gain. The penny stock climbed 3.44% to reach ₹1.80 per share on the Bombay Stock Exchange (BSE). This positive momentum was backed by significantly higher trading volumes, indicating heightened investor interest.
Heavy Volumes Drive the Rally
Trading activity for Evexia Lifecare saw a substantial spike, which played a key role in supporting the price increase. Data showed that approximately 20 lakh equity shares were traded on the BSE on November 17. This figure stands well above the stock's one-week average trading volume of 17 lakh shares, underscoring the heightened activity around the healthcare firm.
Quarterly Results Reveal a Profit Plunge
The company's recent financial disclosures paint a contrasting picture to the short-term stock performance. Evexia Lifecare announced its consolidated results for the second quarter of the fiscal year 2026 (Q2 FY26), reporting a net profit of ₹37.19 lakh. This represents a dramatic decrease of over 60% compared to the ₹93.80 lakh profit recorded in the same quarter last year (YoY). Sequentially, the profit also fell from the ₹63.48 lakh posted in the June 2025 quarter.
On the revenue front, the company's consolidated revenue from operations in Q2 FY26 was ₹25.72 crore. This marks a slight decline from the ₹26.70 crore reported in the year-ago period. However, it showed an improvement from the ₹22.09 crore revenue generated in the preceding June quarter.
Long-Term Performance Remains Under Pressure
Despite the recent gains, a look at the broader timeline reveals a persistent downward trend for the Evexia Lifecare share price. The stock has faced significant erosion in value across multiple time frames. It has fallen by 13% in the past month and declined by 24% over the last three months. The performance over a six-month period shows a steeper drop of 36%.
On a year-to-date (YTD) basis, the stock has plunged by 50%. Over the past one year, the decline is even more pronounced at 56%. In a stark contrast to these losses, the stock has managed a modest gain of just 7% over a three-year horizon, highlighting its volatile and generally weak long-term trajectory.
Evexia Lifecare is identified as a smallcap diversified healthcare company. Its business operations primarily involve the trading of pharmaceutical chemicals, which contributes the largest share to its revenue. The company is also engaged in retail pharmacy services, diagnostic solutions, and the sale of personal healthcare products.
By 2:50 PM on Monday, the Evexia Lifecare share price was trading with a slight gain of 0.57% at ₹1.75 per share on the BSE.
